Jinsei Maruyama - Taisho Pharmaceutical Co Officer
Insider
Jinsei Maruyama is Co Officer of Taisho Pharmaceutical Holdings
| Phone | 81 3 3985 2020 |
| Web | https://www.taisho-holdings.co.jp |
Taisho Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mairead Nayager | Haleon plc | 49 | |
| Brian McNamara | Haleon plc | 59 | |
| Amir Weiss | Teva Pharma Industries | 48 | |
| Marvin White | Emergent Biosolutions | 58 | |
| P Yugandhar | Dr Reddys Laboratories | 49 | |
| Scott Ferguson | Elanco Animal Health | 46 | |
| Mukesh Rathi | Dr Reddys Laboratories | 45 | |
| Jonathan MD | Pacira BioSciences, | 50 | |
| MS BTech | Dr Reddys Laboratories | 58 | |
| Tal Zaks | Teva Pharma Industries | 55 | |
| Penny Wan | Dr Reddys Laboratories | N/A | |
| CS CGP | HUTCHMED DRC | 70 | |
| Abbas Hussain | Teva Pharma Industries | 55 | |
| Karen Smith | Emergent Biosolutions | 52 | |
| Charles Nixon | HUTCHMED DRC | 55 | |
| Paul Herendeen | Elanco Animal Health | 65 | |
| Andrew Weil | Teva Pharma Industries | 52 | |
| ACGI BSc | HUTCHMED DRC | 70 | |
| Dirk Ehle | Elanco Animal Health | 50 | |
| Sanjeev Sethi | Viatris | 57 | |
| MBA MBA | Dr Reddys Laboratories | 55 | |
Management Performance
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 |
Taisho Pharmaceutical Leadership Team
Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director | ||
| Shinichi Tanaka, Gen Communications | ||
| Akira Uehara, President Chairman of Subsidiary, Representative Director | ||
| Jinsei Maruyama, Co Officer | ||
| Tetsu Watanabe, Executive Director | ||
| Jun Kuroda, Ex Director | ||
| Ken Uehara, MD Director | ||
| Hideki Iuchi, G Mang | ||
| Hisashi Umeoka, Director |
Taisho Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |